252 related articles for article (PubMed ID: 11177300)
21. [Phospholipid content of subfractions of high density lipoproteins in women with angiographically documented coronary arteriosclerosis].
Maĭ FT; Liakishev AA; Polesskiĭ VA; Sidorenko BA; Gerasimova EN
Kardiologiia; 1983 Mar; 23(3):33-7. PubMed ID: 6855058
[TBL] [Abstract][Full Text] [Related]
22. High density lipoproteins (HDL).
Med Lett Drugs Ther; 1979 Jan; 21(1):2-3. PubMed ID: 215890
[No Abstract] [Full Text] [Related]
23. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
24. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
25. High-density lipoprotein cholesterol in Thai adults: study in a selected population free of coronary heart diseases and in diabetics.
Viseshakul D; Chularojamontri V; Premwatana P; Chuprasert S; Palachewin K
J Med Assoc Thai; 1980 May; 63(5):257-66. PubMed ID: 7391705
[No Abstract] [Full Text] [Related]
26. [Spontaneous variations of lipid fractions in normal and hyperlipidemic patients].
Forti N; Giannini SD; de Góis JM; Dereviacki BE; de Serro-Azul LG
Arq Bras Cardiol; 1984 Mar; 42(3):177-81. PubMed ID: 6477188
[No Abstract] [Full Text] [Related]
27. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
[TBL] [Abstract][Full Text] [Related]
28. [Important of determining the high-density lipoprotein cholesterol concentration for assessing the lipid metabolic state].
Danilenko MV; Ivaniv IuA; Sheĭman IB; Buryĭ IV
Vrach Delo; 1982 Feb; (2):70-2. PubMed ID: 7064458
[No Abstract] [Full Text] [Related]
29. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
[TBL] [Abstract][Full Text] [Related]
30. [Subclasses of serum HDL in hyperlipidemia].
Xu Y; Fu M; Liu B; Xu Y; Yao J; Zhang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):238-41. PubMed ID: 12947699
[TBL] [Abstract][Full Text] [Related]
31. [Hypolipidemic activity of trimethylglycine].
Kliueva NN; Kalashnikova NM; Okunevich IV; Sapronov NS
Eksp Klin Farmakol; 2012; 75(1):16-8. PubMed ID: 22442957
[TBL] [Abstract][Full Text] [Related]
32. [Serum alpha lipoprotein cholesterol concentration in healthy persons and in ischemic heart disease patients].
Barats SS; Plotnikova SI; Platonova NN
Ter Arkh; 1981; 53(8):13-7. PubMed ID: 7292332
[No Abstract] [Full Text] [Related]
33. Guidelines for cholesterol management: recommendations of the National Cholesterol Education Program's Adult Treatment Panel II.
Grundy SM
Heart Dis Stroke; 1994; 3(3):123-7. PubMed ID: 8044423
[No Abstract] [Full Text] [Related]
34. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
[TBL] [Abstract][Full Text] [Related]
35. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
[TBL] [Abstract][Full Text] [Related]
36. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.
Okazaki M; Usui S; Ishigami M; Sakai N; Nakamura T; Matsuzawa Y; Yamashita S
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):578-84. PubMed ID: 15637308
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus.
Scharnagl H; Winkler K; Mantz S; Baumstark MW; Wieland H; März W
Exp Clin Endocrinol Diabetes; 2004 May; 112(5):269-77. PubMed ID: 15146374
[TBL] [Abstract][Full Text] [Related]
38. [Content of the main lipid components in blood serum lipoproteins of human and of various animal species].
Lizenko MV; Regerand TI; Bakhirev AM; Petrovskiĭ VI; Lizenko EI
Zh Evol Biokhim Fiziol; 2007; 43(2):155-61. PubMed ID: 17674708
[TBL] [Abstract][Full Text] [Related]
39. [Effect of exertion on blood serum high-density lipoproteins].
Halawa B
Wiad Lek; 1980 Sep; 33(17):1353-7. PubMed ID: 7456449
[No Abstract] [Full Text] [Related]
40. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
